Journal article icon

Journal article

Metformin and prostate cancer: a new role for an old drug

Abstract:

Since epidemiological studies first demonstrated a potential positive effect of metformin in reducing cancer incidence and mortality, there has been an increased interest in not only better understanding metformin's mechanisms of action but also in exploring its potential anti-cancer effects. In this review, we aim to summarise the current evidence exploring a role for metformin in prostate cancer therapy.Preclinical studies have demonstrated a number of antineoplastic biological effects via ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s11934-017-0693-8

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Oxford college:
St Edmund Hall
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Role:
Author
Publisher:
Springer US Publisher's website
Journal:
Current Urology Reports Journal website
Volume:
18
Issue:
6
Article number:
46
Publication date:
2017-04-25
DOI:
EISSN:
1534-6285
ISSN:
1527-2737
Pmid:
28444639
Source identifiers:
695438
Language:
English
Keywords:
Pubs id:
pubs:695438
UUID:
uuid:87c64e69-d8b0-41bc-8913-16ae352c2476
Local pid:
pubs:695438
Deposit date:
2017-09-14

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP